No significant difference in OS was observed when comparing ‘AML with KMT2A::MLLT3’ and ‘AML with KMT2A rearrangement other than KMT2A::MLLT3’ (Fig. 2F, Supplementary Table 4). Here, KMT2A is linked to acute myeloid leukemia.